Trials / Completed
CompletedNCT03024424
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Utah · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degeneration (AMD), and to assess the impact of presymptomatic genetic testing for choroidal neovascularization (CNV).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Early disclosure | |
| BEHAVIORAL | Late disclosure |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
- First posted
- 2017-01-18
- Last updated
- 2023-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03024424. Inclusion in this directory is not an endorsement.